The abstract is read at the publisher; the summary is JClub's.
A Virtual Brain Twin pipeline for schizophrenia identifies patient-specific neurochemical parameter regimes in a cohort of 33 subjects, including reduced cortical dopaminergic drive and elevated subcortical drive.
- Why it matters: Neuroimaging markers have not translated into reliable personalized diagnosis or treatment selection because linking multimodal brain data to mechanistic, patient-level pathophysiology has been difficult.
- What they did: The method builds personalized whole-brain dynamical models from structural connectivity, cortical thickness, and resting-state fMRI, embeds dopaminergic and serotonergic signaling in a mean-field framework, and uses simulation-based inference validated on synthetic patients.
- The result: In silico pharmacological interventions produce individualized medication effect trajectories matching retrospective outcomes with 66.6% accuracy, supporting VBT-guided antipsychotic selection for prospective trials in Marseille and Munich.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.